Skip to main content

Table 1 Drug classes receiving co-payment reductions: focus on diabetes trial

From: A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial

Glycemic Agents
   Metformin
   Sulfonylureas
   Thiazolidinediones
   All other glycemic agents (except insulin*)
Antihypertensive Agents
   ACE-Inhibitors & Angiotensin Receptor Blockers (ACE/ARB)
   Beta blockers
   Calcium Channel Blockers
   Diuretics
   Other antihypertensives
Lipid-Lowering Agents
   HMG-CoA Reductase Inhibitors (statins)
   Zetia
   Other lipid lowering agents
Antidepressants
   SSRSs/SNRIs
   Tricyclic agents
   Other antidepressants
  1. *At the time of the intervention, M-CARE already waived copayments for Insulin.